将阿尔蒂斯复制体器官系统与MDCK单层进行比较,以预测莱纳利多米德的口服吸收
Cole S Hudson1, Jonathan Cheong2, Jesse Yu2
1Department of Pharmacological & Pharmaceutical Sciences, University of Houston College of Pharmacy, Houston, TX 77004, USA.
Pharmaceutics
|September 27, 2025
概括
与传统的细胞模型相比,人类肠道有机体提供了更准确的口服药物吸收预测,如lenalidomide. 这些有机体更好地解释载体效应,改善体内吸收预测.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物开发 药物开发
- 生物技术是生物技术.
背景情况:
- 预测口服药物吸收在早期药物开发中至关重要.
- 像PAMPA和MDCK细胞这样的常规体外模型对某些药物类别有局限性.
- 人类肠道有机体是预测药物吸收的新兴,有希望的替代品.
研究的目的:
- 使用人类肠道有机物衍生的单层来预测lenalidomide的口服吸收.
- 为了在有机体模型中比较lenalidomide的透性与常规细胞系.
- 通过工程细胞系来评估载体在莱纳利多米德吸收中的作用.
主要方法:
- 人类阴茎器官 (RepliGut®) 被培养成单层.
- 莱纳利多米德的透性在有机单层和各种MDCK细胞系 (野生型,P-gp淘汰,P-gp过度表达,BCRP过度表达) 中进行了评估.
- 在小鼠体内进行了lenalidomide的口服和静脉注射,随后进行了药理动力学分析.
主要成果:
- 列纳利多米德在老鼠中显示出高的口服生物可用性 (68-120%).
- 人类肠道有机体显示,莱纳利多米德的表面透率 (Papp) 约为0.6 × 10−6 cm/s,不论度如何.
- 列纳利多米德帕普在gMDCK细胞中较低 (~0.2 × 10−6 cm/s),并在相关细胞模型中被确定为P-gp/BCRP基质.
结论:
- 马丁 - 达比犬 (MDCK) 细胞透率低估了莱纳利多米德体内吸收.
- 器官系统在捕捉载体介导和细胞对药物透性的影响方面显得优越.
- 与传统的基于细胞的测定相比,肠道器官可以提供更准确的口服药物吸收预测.
相关概念视频
Methods for Studying Drug Absorption: In vitro
574
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
574
Methods for Studying Drug Absorption: In situ
636
In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
636
Bioavailability Study Design: Absolute Versus Relative Bioavailability
301
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
301
Measurement of Bioavailability: Pharmacodynamic Methods
236
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
236
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
505
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
505


